# A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain

> **NCT00713817** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 19 (actual)

## Conditions studied

- Pain
- Peripheral Neuropathy

## Interventions

- **DRUG:** Sativex®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00713817
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713817, "A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00713817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*